⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24665 | 0.72 | — | — | |
| SCHEMBL4646 | 0.72 | — | — | |
| SCHEMBL5821161 | 0.72 | — | — | |
| SCHEMBL33837 | 0.72 | — | — | |
| SCHEMBL1068002 | 0.72 | — | — | |
| SCHEMBL440617 | 0.72 | — | — | |
| SCHEMBL20715 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL6308604 | 0.67 | — | — | |
| SCHEMBL309492 | 0.67 | — | — | |
| Fluoride SCHEMBL11853405 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140288020-A1 | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | GILEAD PHARMASSET LLC (US) | 2014-09-25 | — | — | US | claimed |
| EP-1525212-B1 | METHOD FOR PREPARING OLIGONUCLEOTIDES | GIRINDUS AG (DE) | 2012-09-12 | — | — | EP | claimed |
| EP-2203462-A2 | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | Pharmasset, Inc. (US) | 2010-07-07 | — | — | EP | claimed |
| US-20100016251-A1 | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | PHARMASSET, INC. (US) | 2010-01-21 | — | — | US | claimed |
| WO-2008121634-A2 | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | PHARMASSET, INC. (US) | 2008-10-09 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0773951-B1 | DINUCLEOSIDE-5',5'-PYROPHOSPHATES | BIOSEARCH ITALIA SPA (IT) | 1999-03-10 | — | — | EP | claimed |
| EP-0417604-B1 | Process for preparing riboflavin-5'-phosphate and its sodium salt | BASF AG (DE) | 1995-04-12 | — | — | EP | claimed |
| US-5095115-A | Phosphorylation, salt formation | BASF AKTIENGESELLSCHAFT (DE) | 1992-03-10 | — | — | US | claimed |
| EP-0218099-B1 | AMIDES OF TEICOPLANIN COMPOUNDS | GRUPPO LEPETIT S.p.A. (IT) | 1991-12-11 | — | — | EP | claimed |
| EP-0036077-B1 | ESTERS OF HYDROXYLALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITION CONTAINING THESE ESTERS AS ACTIVE INGREDIENTS | Newport Pharmaceuticals International, Inc. (US) | 1984-08-15 | — | — | EP | claimed |
| JP-59031788-A | — | — | None | — | — | JP | disclosed |
| US-20240180948-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY | 2024-06-06 | — | — | US | disclosed |
| US-20240173345-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SUBSTITUTED NUCLEOTIDE AND NUCLEOSIDE FOR TREATING VIRAL INFECTIONS | EMORY UNIVERSITY | 2024-05-30 | — | — | US | disclosed |
| US-20240165143-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY | 2024-05-23 | — | — | US | disclosed |
| US-4089650-A | Use of Diels-Alder adducts of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors | PETROLITE CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-3998833-A | CORROSION INHIBITORS, MICROBIOCIDES | PETROLITE CORPORATION (US) | 1976-12-21 | — | — | US | disclosed |
| US-3997293-A | Use of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors | PETROLITE CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
| US-3965264-A | DIELS-ALDER ADDUCT OF A PHOSPHORAMIDATE AND A DIENOPHILE | PETROLITE CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |